CM
Caption Management Portfolio holdings
AUM $1.09B
1-Year Return
4.13%
This Quarter Return
+2.11%
1 Year Return
+4.13%
3 Year Return
+12.18%
5 Year Return
+25.84%
10 Year Return
–
AUM
$1.09B
AUM Growth
-$1.1B
(-50%)
Cap. Flow
-$1.2B
Cap. Flow
% of AUM
-110.09%
Top 10 Holdings %
Top 10 Hldgs %
25.17%
Holding
1,115
New
230
Increased
115
Reduced
111
Closed
247
Top Buys
| 1 |
Insmed
INSM
|
+$21.2M |
| 2 |
SKX
Skechers
SKX
|
+$20.1M |
| 3 |
Gilead Sciences
GILD
|
+$16.5M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$16.4M |
| 5 |
Kellanova
K
|
+$14.9M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$394M |
| 2 |
Amazon
AMZN
|
+$314M |
| 3 |
NVIDIA
NVDA
|
+$255M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$130M |
| 5 |
Cisco
CSCO
|
+$61.7M |
Sector Composition
| 1 | Healthcare | 25.54% |
| 2 | Consumer Discretionary | 20.68% |
| 3 | Technology | 13.45% |
| 4 | Financials | 8.7% |
| 5 | Communication Services | 6.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Appian
APPN
$2.33B
| $2.4M | 0.03% |
80,472
-14,242
| -15% | -$425K |
|
127
Alamos Gold
AGI
$13.2B
| $2.38M | 0.03% |
89,591
-72,284
| -45% | -$1.92M |
|
128
ING
ING
$74.5B
| $2.37M | 0.03% |
108,500
| – | – |
|
|
AVDL
129
Avadel Pharmaceuticals
AVDL
$1.52B
| $2.34M | 0.03% |
264,910
| – | – |
|
130
CoStar Group
CSGP
$37.2B
| $2.33M | 0.03% |
29,000
+13,552
| +88% | +$1.09M |
|
131
AES
AES
$8.91B
| $2.32M | 0.03% |
220,300
+211,000
| +2,269% | +$2.22M |
|
|
132
Alphabet (Google) Class A
GOOGL
$3.02T
| $2.27M | 0.03% |
12,900
-738,750
| -98% | -$130M |
|
133
Urban Outfitters
URBN
$6.29B
| $2.27M | 0.03% |
+31,300
| New | +$2.27M |
|
134
The GEO Group
GEO
$3.06B
| $2.25M | 0.02% |
93,843
+93,058
| +11,855% | +$2.23M |
|
135
Franco-Nevada
FNV
$38.7B
| $2.17M | 0.02% |
13,245
+8,245
| +165% | +$1.35M |
|
136
Globus Medical
GMED
$7.59B
| $2.15M | 0.02% |
+36,507
| New | +$2.15M |
|
137
MetLife
MET
$52.3B
| $2.13M | 0.02% |
+26,500
| New | +$2.13M |
|
138
Recursion Pharmaceuticals
RXRX
$2.06B
| $2.13M | 0.02% |
+420,801
| New | +$2.13M |
|
139
NextNav
NN
$2.32B
| $2.06M | 0.02% |
135,478
-72,954
| -35% | -$1.11M |
|
140
Groupon
GRPN
$886M
| $2.05M | 0.02% |
61,282
-433,958
| -88% | -$14.5M |
|
141
Baxter International
BAX
$11.9B
| $2.04M | 0.02% |
+67,500
| New | +$2.04M |
|
142
Synchrony
SYF
$27.8B
| $2M | 0.02% |
+30,000
| New | +$2M |
|
143
Larimar Therapeutics
LRMR
$349M
| $1.99M | 0.02% |
+689,290
| New | +$1.99M |
|
144
Brighthouse Financial
BHF
$2.63B
| $1.99M | 0.02% |
+37,000
| New | +$1.99M |
|
145
British American Tobacco
BTI
$122B
| $1.99M | 0.02% |
+42,000
| New | +$1.99M |
|
146
Amphenol
APH
$145B
| $1.98M | 0.02% |
20,000
+12,000
| +150% | +$1.19M |
|
147
ADMA Biologics
ADMA
$3.71B
| $1.97M | 0.02% |
+108,000
| New | +$1.97M |
|
148
Allot
ALLT
$431M
| $1.93M | 0.02% |
226,146
-44,435
| -16% | -$380K |
|
149
National Vision
EYE
$1.97B
| $1.91M | 0.02% |
83,000
-14,099
| -15% | -$324K |
|
150
CAE Inc
CAE
$8.62B
| $1.9M | 0.02% |
+65,000
| New | +$1.9M |
|